Frequency of Thrombocytopenia in Patients Infected with Hepatitis C Virus Infection of a Tertiary Care Hospital
Thrombocytopenia in HCV-Infected Patients
DOI:
https://doi.org/10.61919/jhrr.v4i3.1250Keywords:
Thrombocytopenia, HCV infection, HCV-associated thrombocytopeniaAbstract
Background: Hepatitis C Virus (HCV) infection is a global health issue, particularly prevalent in Pakistan. HCV can cause significant liver damage and various hematologic abnormalities, including thrombocytopenia, which increases the risk of bleeding and bruising.
Objective: This study aimed to determine the frequency of thrombocytopenia in patients infected with HCV at a tertiary care hospital and to explore the associations with demographic and clinical characteristics.
Methods: A cross-sectional study was conducted over six months, enrolling 200 HCV-reactive patients aged 18-65 years, excluding those with liver cirrhosis, chronic liver disease, liver cancer, end-stage renal disease, coexisting viral infections, and pregnant females. Venous blood samples were collected to confirm HCV through real-time polymerase chain reaction (RT-PCR) and to perform a complete blood count (CBC) for platelet (PLT) count. Data were analyzed using SPSS version 25.0, with quantitative variables summarized as mean and standard deviation, and qualitative variables expressed as frequencies and percentages. Associations between thrombocytopenia and various factors were evaluated using the chi-square test.
Results: Of the 200 patients, 72 (36.00%) were males and 128 (64.00%) females, with a mean age of 42.71 ± 13.164 years. Thrombocytopenia (PLT count <150 x 10^9/L) was present in 47 (23.50%) patients. No statistically significant associations were found between thrombocytopenia and demographic or clinical characteristics, except for a weak association with the history of previous surgery (p=0.048). The mean PLT count was 213.53 ± 79.546 x 10^9/L.
Conclusion: A significant proportion of HCV-infected patients had thrombocytopenia, with a higher prevalence observed among females. The findings underscore the need for regular monitoring of platelet counts in HCV patients to prevent and manage complications.
Downloads
References
Dunn R, Wetten A, McPherson S, Donnelly MC. Viral hepatitis in 2021: The challenges remaining and how we should tackle them. World Journal of Gastroenterology. 2022;28(1):76. doi: 10.3748/wjg.v28.i1.76
Ullah N, Kakakhel M, Bai Y, Xi L, Khan I, Kalra B, et al. Prevalence of active HCV infection and genotypic distribution among the general population of district Mardan, Pakistan. Brazilian Journal of Biology. 2021;83:e244977. https://doi.org/10.1590/1519-6984.244977
Kishta S, Tabll A, Omanovic Kolaric T, Smolic R, Smolic M. Risk factors contributing to the occurrence and recurrence of hepatocellular carcinoma in hepatitis C virus patients treated with direct-acting antivirals. Biomedicines. 2020;8(6):175. https://doi.org/10.3390/biomedicines8060175
Santoshi RK, Patel R, Patel NS, Bansro V, Chhabra G, Chhabra GS. A comprehensive review of thrombocytopenia with a spotlight on intensive care patients. Cureus. 2022;14(8). DOI: 10.7759/cureus.27718
Sigal SH, Sherman Z, Jesudian A. Clinical implications of thrombocytopenia for the cirrhotic patient. Hepatic Medicine: Evidence and Research. 2020:49-60. doi.org/10.2147/HMER.S244596
Babu DV, Palaparthi Srinivas DMM, Melissa YS. A hospital-based study to investigate the clinical and haematological characteristics of patients with dengue fever. 2023. I: https://doi.org/10.22271/23487941.2023.v10.i6b.725
Jaime-Pérez JC, Ramos-Dávila EM, Meléndez-Flores JD, Gómez-De León A, Gómez-Almaguer D. Insights on chronic immune thrombocytopenia pathogenesis: a bench to bedside update. Blood Reviews. 2021;49:100827. https://doi.org/10.1016/j.blre.2021.100827
Rawi S, Wu GY. Pathogenesis of thrombocytopenia in chronic HCV infection: a review. Journal of clinical and translational hepatology. 2020;8(2):184. doi: 10.14218/JCTH.2020.00007
Huang C-E, Chen W-M, Wu Y-Y, Shen C-H, Hsu C-C, Li C-P, et al. Comparison of antiplatelet antibody profiles between hepatitis C virus-associated immune thrombocytopenia and primary immune thrombocytopenia. Platelets. 2021;32(8):1043-50. https://doi.org/10.1080/09537104.2020.1820975
Ryou M, Stylopoulos N, Baffy G. Nonalcoholic fatty liver disease and portal hypertension. Exploration of medicine. 2020;1:149. doi: 10.37349/emed.2020.00011
Soliman Z, El Kassas M, Elsharkawy A, Elbadry M, Hamada Y, ElHusseiny R, et al. Improvement of platelet in thrombocytopenic HCV patients after treatment with direct-acting antiviral agents and its relation to outcome. Platelets. 2021;32(3):383-90. https://doi.org/10.1080/09537104.2020.1742313
Hsu S-J, Yang S-S, Kao J-H. Risk of hepatocellular carcinoma development after hepatitis C virus eradicated by direct-acting antivirals: Fact or fiction? Journal of the Formosan Medical Association. 2020;119(1):3-11. https://doi.org/10.1016/j.jfma.2019.09.006
RAZIQ MA, HUSSAIN B, WAHHAJ MUNIR FQ. A Study of Thrombocytopenia in cases of Hepatitis C infection presenting at tertiary care hospital. Pakistan Journal of Medical and Health Sciences. 2021;15(5):926-8. https://doi.org/10.53350/pjmhs21155926
Ain QU, Zameer H, Haroon A, Kadir S, Mazhar N, Laique T. Haematological Changes in Hepatitis C (HCV) Patients. Pakistan Journal of Medical & Health Sciences. 2022;16(04):126-. https://doi.org/10.53350/pjmhs22164126
Rehman S, Rahman S, Khan S, Ahmad N, Rahman N. Frequency of thrombocytopenia in hepatitis c patients. Journal of Medical Sciences. 2019;27(3):190-3. https://jmedsci.com/index.php/Jmedsci/article/view/731
Huang C-E, Chang J-J, Wu Y-Y, Huang S-H, Chen W-M, Hsu C-C, et al. Different impacts of common risk factors associated with thrombocytopenia in patients with hepatitis B virus and hepatitis C virus infection. biomedical journal. 2022;45(5):788-97. https://doi.org/10.1016/j.bj.2021.09.001
Rehman MUU, Afzal A, Mumtaz M, Zubair M, Bhutta N, Iqbal J. Frequency of HCV induced thrombocytopenia in Southern Punjab. Pakistan Journal of Medical & Health Sciences. 2022;16(09):991-. https://doi.org/10.53350/pjmhs22169991
Sarwar K, Zahoor SZ, Tipu I. HCV induced thrombocytopenia in Punjab, Pakistan. BioScientific Review. 2020;2(1):19–27-19–27.https://doi.org/10.32350/BSR.0201.03
ZARA MEHMOOD C, SHAH ZH, SAJAD Q, FAROOQ N, CH S. Frequency of Thrombocytopenia and its Severity among patients of Chronic Liver Disease presenting to a Tertiary Care Hospital. https://doi.org/10.53350/pjmhs22161155
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Eesha Tariq Bhatty, Sania Ahmed, Minahil Rathor, Sheeza Nighat, Maria Anwar, Saba Idrees, Zainab Yousaf
This work is licensed under a Creative Commons Attribution 4.0 International License.
